"But Elsevier bought Mendeley and SSRN, and they're OK, aren't they?"

Mike Taylor

doi:10.59350/dvz97-jfg60

May 11, 2017Open Access

"But Elsevier bought Mendeley and SSRN, and they're OK, aren't they?"

View Full Paper

Ask AI

Bookmark

Share

Key Points

Mixed feelings exist regarding Elsevier's acquisition of SSRN and Mendeley, as opinions vary widely.
Some users, like Brian Lucey, have found SSRN consistently useful, suggesting a positive view of Elsevier's impact.
The discussion revolves around the role of Elsevier in the preprint space and its implications for the academic community.
Despite criticism of Elsevier, the utility of acquisitions like Mendeley and SSRN continues to be acknowledged by some users.

Implication

Commentary highlights varying opinions on Elsevier's entry into preprints, indicating mixed sentiments about SSRN's value.

Abstract

This tired old argument came up again on Twitter this evening, in light of Elsevier's me-too announcement of a preprint archive: Brian Nosek‏: Elsevier enters the biology #preprints space: https://www.elsevier.com/solutions/ssrn/biorn Me: KILL IT WITH FIRE Brian Lucey‏: I've used SSRN from its inception. Never ever felt it as anything but useful. That's not changed with Elsevier.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mike Taylor (2017) studied this question.

synapsesocial.com/papers/68eb6f7ceea689731b300553 https://doi.org/10.59350/dvz97-jfg60

View Full Paper

Ask AI

Bookmark

Share

"But Elsevier bought Mendeley and SSRN, and they're OK, aren't they?"

Key Points

Implication

Abstract

Discussion

Cite This Study

"But Elsevier bought Mendeley and SSRN, and they're OK, aren't they?"

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading